爱思唯尔撤销中国9篇论文 因同行评审造假

据Retraction Watch网站消息，因论文同行评审造假，爱思唯尔出版商撤销旗下5本杂志中的9篇论文，这9篇论文全部来自中国高校或研究机构。

爱思唯尔发出声明称，出版伦理委员会调查发现这9篇论文的同行评审过程被人为操纵，随后爱思唯尔便撤销了这9篇论文。

自2012年来，爱思唯尔因同行评审造假而撤销的论文超过了20篇，所有出版商中因同行评审造假而被撤销的论文多达260篇。

爱思唯尔计划采用新的编辑系统，可以自动化验证电子邮件地址是否合法。爱思唯尔还采用了其他一系列方法来阻止同行评审造假再次发生。

附：9篇论文链接

1：Predictive and prognostic value of ER-α36 expression in breast cancer patients treated with chemotherapy

2：The synergistic effect between β-amyloid1–42 and α-synuclein on the synapses dysfunction in hippocampal neurons

3：Protein–protein interaction and SNP analysis in intraductal papillary mucinous neoplasm

4：Candidate agents for pancreatic ductal adenocarcinoma identified by a sub-pathway based method

5：Microarray analysis of microRNA expression in liver cancer tissues and normal control

6：Association of TNF-α-308G>A polymorphisms with hepatocellular carcinoma in Han Chinese population： A systematic review and meta-analysis

7：Correlations between peroxisome proliferator activator receptor γ， Cystatin C， or advanced oxidation protein product， and atherosclerosis in diabetes patients

8：The rapid and sustained responses of dendritic cells to influenza virus infection in a non-human primate model

9：Antiviral and myocyte protective effects of IL-28A in coxsackievirus B3-induced myocarditis

信源：Elsevier retracting nine papers for fake peer review

（原文标题：爱思唯尔因同行评审造假撤销中国9篇论文）